Promising cancer drug seeking clinical trials
Two of the world’s most acclaimed cancer researchers have announced a major breakthrough in cancer drugs.
Dr. Tak Mak of the Princess Margaret Cancer Centre and Dennis Slamon of the University of California, announced a new drug that will enter clinical trials in a few months. The drug has been shown to effectively prevent the growth of breast and ovarian cancers among others. The drug will be reviewed by the FDA and Health Canada before it moves to the clinical testing stage.
[projekktor src=’https://488b0f6bbd6e1f02d285-a9990803a5649dd3960d912508d8bce9.ssl.cf2.rackcdn.com/2013-0618DrugEN62.mp4′]
